×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Aprea Therapeutics Inc. (APRE) NASDAQ

$6.61 0.54 (8.90%)

Market Cap: $32.96M

As of 03/28/24 03:59 PM EDT. Market closed.

(APRE)

Aprea Therapeutics Inc. (APRE)
NASDAQ

$6.61
0.54 (8.90%)

Market Cap: $32.96M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

annan naturvetenskaplig och teknisk forskning och ... read more

annan naturvetenskaplig och teknisk forskning och utveckling read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
3
URL
Address
.
PRICE CHART FOR APREA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.92
Previous Close
$6.07
Days Range
$5.97 - $6.31
52 week range
$2.78 - $8.85
Volume
28,785
Avg. Volume (30 days)
76,298
Market Cap
$32.96M
Dividend Yield
-
P/E
-
Shares Outstanding
5,430,215
Open
$5.92
Previous Close
$6.07
Days Range
$5.97 - $6.31
52 week range
$2.78 - $8.85
Volume
28,785
Avg. Volume (30 days)
76,298
Market Cap
$32.96M
Dividend Yield
-
P/E
-
Shares Outstanding
5,430,215
FINANCIAL STATEMENTS FOR APREA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APREA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hamill John P.SrVP/CFO/Prin Fin & Acct OfcrMar 13, 2024 Buy$7.291,0107,36315,503Mar 14, 2024, 08:54 PM
Seizinger Bernd R.DirectorMar 13, 2024 Buy$7.296,86050,00933,685Mar 14, 2024, 08:53 PM
HENNEMAN JOHN B IIIDirectorMar 13, 2024 Buy$7.296,86050,0098,139Mar 14, 2024, 08:52 PM
Gilad OrenPresident, CEOMar 13, 2024 Buy$7.292,00014,580324,770Mar 14, 2024, 08:51 PM
Seizinger Bernd R.DirectorJun 07, 2023 Buy$3.686,02922,19226,325Jun 08, 2023, 04:34 PM
Seizinger Bernd R.DirectorJun 06, 2023 Buy$3.634,06814,76420,296Jun 08, 2023, 04:34 PM
Hamill John P.SrVP/CFO/Prin Fin & Acct OfcrFeb 27, 2023 Option Exercise$5.251,0005,25014,493Feb 27, 2023, 06:37 PM
SCHADE CHRISTIAN SChairman & CEOJun 03, 2022 Option Exercise$0.8165,77052,945226,846Jun 07, 2022, 05:05 PM
Coiante Scott MSVP, Chief Financial OfficerJun 03, 2022 Option Exercise$0.8135,28428,40484,265Jun 07, 2022, 05:02 PM
Korbel Gregory AlanSVP, Chief Operating OfficerJun 03, 2022 Option Exercise$0.818,3906,75421,462Jun 07, 2022, 05:01 PM
Attar Eyal C.SVP, Chief Medical OfficerJun 03, 2022 Option Exercise$0.8132,66726,29757,233Jun 07, 2022, 05:00 PM
Seizinger Bernd R.DirectorMay 18, 2022 Buy$0.7150,00035,500318,580May 19, 2022, 04:31 PM
SCHADE CHRISTIAN SChairman & CEOMay 18, 2022 Buy$0.6437,50024,124292,616May 19, 2022, 04:30 PM
Korbel Gregory AlanSVP, Chief Business OfficerMar 10, 2022 Option Exercise$1.821,9893,62029,852Mar 14, 2022, 05:03 PM
SCHADE CHRISTIAN SChairman & CEOFeb 25, 2022 Option Exercise$1.7421,64437,661155,016Mar 01, 2022, 05:02 PM
Korbel Gregory AlanSVP, Chief Business OfficerFeb 25, 2022 Option Exercise$1.741,3262,30715,841Mar 01, 2022, 05:02 PM
Coiante Scott MSVP, Chief Financial OfficerFeb 25, 2022 Option Exercise$1.7414,81725,78276,649Mar 01, 2022, 05:01 PM
Attar Eyal C.SVP, Chief Medical OfficerFeb 28, 2022 Sale$1.7336,00062,28047,000Mar 01, 2022, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerDec 01, 2021 Option Exercise$0.9227,50025,30044,667Dec 03, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerDec 01, 2021 Sale$3.9627,500108,90017,167Dec 03, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerNov 01, 2021 Option Exercise$0.9227,50025,30044,667Nov 03, 2021, 05:34 PM
Korbel Gregory AlanSVP, Chief Business OfficerNov 01, 2021 Sale$5.0027,500137,50017,167Nov 03, 2021, 05:34 PM
Abrahmsen Lars B.SVP, Chief Scientific OfficerOct 01, 2021 Option Exercise$0.9250,00046,00069,000Oct 05, 2021, 05:01 PM
Abrahmsen Lars B.SVP, Chief Scientific OfficerOct 01, 2021 Sale$4.8950,000244,50019,000Oct 05, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerOct 01, 2021 Option Exercise$0.9227,50025,30044,667Oct 05, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerOct 01, 2021 Sale$4.8927,500134,47517,167Oct 05, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerSep 20, 2021 Option Exercise$0.9227,50025,30044,667Sep 22, 2021, 05:01 PM
Korbel Gregory AlanSVP, Chief Business OfficerSep 20, 2021 Sale$4.9732,960163,86617,167Sep 22, 2021, 05:01 PM
Abrahmsen Lars B.SVP, Chief Scientific OfficerSep 20, 2021 Option Exercise$0.9225,00023,00044,000Sep 22, 2021, 05:00 PM
Abrahmsen Lars B.SVP, Chief Scientific OfficerSep 20, 2021 Sale$4.9725,000124,25019,000Sep 22, 2021, 05:00 PM
Attar Eyal C.SVP, Chief Medical OfficerSep 16, 2021 Sale$4.6815,96874,73083,000Sep 20, 2021, 05:29 PM
Korbel Gregory AlanChief Business OfficerSep 10, 2021 Option Exercise$4.591,7247,91322,627Sep 14, 2021, 05:01 PM
Korbel Gregory AlanChief Business OfficerAug 25, 2021 Option Exercise$3.981,1494,57324,351Aug 27, 2021, 05:02 PM
Coiante Scott MSVP, Chief Financial OfficerAug 25, 2021 Option Exercise$3.987,53429,98591,466Aug 27, 2021, 05:01 PM
Attar Eyal C.SVP, Chief Medical OfficerAug 25, 2021 Option Exercise$3.989,03235,94798,968Aug 27, 2021, 05:00 PM
Redmile Group, LLC10% OwnerDec 28, 2020 Sale$5.58500,0002,791,2901,774,581Feb 16, 2021, 04:11 PM
5AM Ventures IV, L.P.Former 10% holderOct 05, 2020 Sale$25.30175,0004,427,500138,497Oct 07, 2020, 09:30 PM
KDev Investments AB10% OwnerJul 07, 2020 Sale$34.55241,7038,350,8381,992,586Jul 07, 2020, 05:41 PM
ROCKLAGE SCOTT MDirectorJun 16, 2020 Sale$33.30120,1644,001,4611,823,192Jun 18, 2020, 07:23 PM
5AM Ventures IV, L.P.10% OwnerJun 16, 2020 Sale$33.30140,0004,662,0001,823,192Jun 18, 2020, 07:22 PM
ROCKLAGE SCOTT MDirectorJun 11, 2020 Sale$28.75245,0007,044,4121,938,549Jun 15, 2020, 09:13 PM
5AM Ventures IV, L.P.10% OwnerJun 11, 2020 Sale$28.75245,0007,044,4121,938,549Jun 15, 2020, 09:12 PM
ROCKLAGE SCOTT MDirectorMay 19, 2020 Sale$35.15255,0008,963,2502,173,748May 21, 2020, 09:32 PM
5AM Ventures IV, L.P.10% OwnerMay 19, 2020 Sale$35.15255,0008,963,2502,173,748May 21, 2020, 09:31 PM
KDev Investments AB10% OwnerApr 13, 2020 Sale$31.25210,5486,579,6252,234,289Apr 15, 2020, 09:18 AM
5AM Ventures IV, L.P.10% OwnerOct 07, 2019 Buy$15.00333,3334,999,995333,333Oct 09, 2019, 06:23 PM
Redmile Group, LLC10% OwnerOct 07, 2019 Buy$15.00400,0006,000,0002,268,718Oct 08, 2019, 08:13 PM
HealthCap VII, L.P.10% OwnerOct 07, 2019 Buy$15.00266,6674,000,0052,366,104Oct 07, 2019, 07:53 PM
Versant Vantage I, L.P.10% OwnerOct 07, 2019 Buy$15.00333,3334,999,995333,333Oct 07, 2019, 07:40 PM
Versant V Luxco S.a r.l.10% OwnerOct 07, 2019 Buy$15.00333,3334,999,995333,333Oct 07, 2019, 07:39 PM
Christenson JohanDirectorOct 07, 2019 Buy$15.00266,6674,000,0052,366,104Oct 07, 2019, 07:33 PM
Seizinger Bernd R.DirectorOct 07, 2019 Option Exercise$0.07263,97018,478263,970Oct 07, 2019, 07:33 PM
Magni GuidoDirectorOct 07, 2019 Buy$15.006,50097,5006,500Oct 07, 2019, 07:25 PM
HENNEMAN JOHN B IIIDirectorOct 07, 2019 Buy$15.005,00075,0005,000Oct 07, 2019, 07:23 PM
Korbel Gregory AlanVP of Business Dev'tOct 07, 2019 Buy$15.005007,500500Oct 07, 2019, 07:21 PM
Attar Eyal C.SVP, Chief Medical OfficerOct 07, 2019 Buy$15.002003,000200Oct 07, 2019, 07:18 PM
Attar Eyal C.SVP, Chief Medical OfficerOct 07, 2019 Buy$15.002003,000200Oct 07, 2019, 07:18 PM
Coiante Scott MSVP, Chief Financial OfficerOct 07, 2019 Buy$15.002,50037,5002,500Oct 07, 2019, 07:15 PM
SCHADE CHRISTIAN SPresident & CEOOct 07, 2019 Buy$15.005,00075,0005,000Oct 07, 2019, 07:15 PM
SCHADE CHRISTIAN SPresident & CEOOct 07, 2019 Buy$15.006,00090,0001,000Oct 07, 2019, 07:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr03/13/20247,363
Seizinger Bernd R.Director03/13/202450,009
HENNEMAN JOHN B IIIDirector03/13/202450,009
Gilad OrenPresident, CEO03/13/202414,580
Seizinger Bernd R.Director06/07/202322,192
Seizinger Bernd R.Director06/06/202314,764
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr02/27/20235,250
SCHADE CHRISTIAN SChairman & CEO06/03/202252,945
Coiante Scott MSVP, Chief Financial Officer06/03/202228,404
Korbel Gregory AlanSVP, Chief Operating Officer06/03/20226,754
Attar Eyal C.SVP, Chief Medical Officer06/03/202226,297
Seizinger Bernd R.Director05/18/202235,500
SCHADE CHRISTIAN SChairman & CEO05/18/202224,124
Korbel Gregory AlanSVP, Chief Business Officer03/10/20223,620
SCHADE CHRISTIAN SChairman & CEO02/25/202237,661
Korbel Gregory AlanSVP, Chief Business Officer02/25/20222,307
Coiante Scott MSVP, Chief Financial Officer02/25/202225,782
Attar Eyal C.SVP, Chief Medical Officer02/28/202262,280
Korbel Gregory AlanSVP, Chief Business Officer12/01/202125,300
Korbel Gregory AlanSVP, Chief Business Officer12/01/2021108,900
Korbel Gregory AlanSVP, Chief Business Officer11/01/202125,300
Korbel Gregory AlanSVP, Chief Business Officer11/01/2021137,500
Abrahmsen Lars B.SVP, Chief Scientific Officer10/01/202146,000
Abrahmsen Lars B.SVP, Chief Scientific Officer10/01/2021244,500
Korbel Gregory AlanSVP, Chief Business Officer10/01/202125,300
Korbel Gregory AlanSVP, Chief Business Officer10/01/2021134,475
Korbel Gregory AlanSVP, Chief Business Officer09/20/202125,300
Korbel Gregory AlanSVP, Chief Business Officer09/20/2021163,866
Abrahmsen Lars B.SVP, Chief Scientific Officer09/20/202123,000
Abrahmsen Lars B.SVP, Chief Scientific Officer09/20/2021124,250
Attar Eyal C.SVP, Chief Medical Officer09/16/202174,730
Korbel Gregory AlanChief Business Officer09/10/20217,913
Korbel Gregory AlanChief Business Officer08/25/20214,573
Coiante Scott MSVP, Chief Financial Officer08/25/202129,985
Attar Eyal C.SVP, Chief Medical Officer08/25/202135,947
Redmile Group, LLC10% Owner12/28/20202,791,290
5AM Ventures IV, L.P.Former 10% holder10/05/20204,427,500
KDev Investments AB10% Owner07/07/20208,350,838
ROCKLAGE SCOTT MDirector06/16/20204,001,461
5AM Ventures IV, L.P.10% Owner06/16/20204,662,000
ROCKLAGE SCOTT MDirector06/11/20207,044,412
5AM Ventures IV, L.P.10% Owner06/11/20207,044,412
ROCKLAGE SCOTT MDirector05/19/20208,963,250
5AM Ventures IV, L.P.10% Owner05/19/20208,963,250
KDev Investments AB10% Owner04/13/20206,579,625
5AM Ventures IV, L.P.10% Owner10/07/20194,999,995
Redmile Group, LLC10% Owner10/07/20196,000,000
HealthCap VII, L.P.10% Owner10/07/20194,000,005
Versant Vantage I, L.P.10% Owner10/07/20194,999,995
Versant V Luxco S.a r.l.10% Owner10/07/20194,999,995
Christenson JohanDirector10/07/20194,000,005
Seizinger Bernd R.Director10/07/201918,478
Magni GuidoDirector10/07/201997,500
HENNEMAN JOHN B IIIDirector10/07/201975,000
Korbel Gregory AlanVP of Business Dev't10/07/20197,500
Attar Eyal C.SVP, Chief Medical Officer10/07/20193,000
Attar Eyal C.SVP, Chief Medical Officer10/07/20193,000
Coiante Scott MSVP, Chief Financial Officer10/07/201937,500
SCHADE CHRISTIAN SPresident & CEO10/07/201975,000
SCHADE CHRISTIAN SPresident & CEO10/07/201990,000
Load More Insider Transactions
FUNDS WITH A POSITION IN APREA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC17,4730.00001%No changeOther
BLACKROCK INC.8,5040%-7.87%Other
CHANGE IN SHARES OUTSTANDING FOR APREA THERAPEUTICS INC
STOCK BUYBACKS FOR APREA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.08%
1Q
12/31/2023
06/30/2023
0.17%
2Q
12/31/2023
03/31/2023
14.65%
3Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.08%
1Q
06/30/2023
0.17%
2Q
03/31/2023
14.65%
3Q
BUYBACK ANNOUNCEMENT(S) FOR APREA THERAPEUTICS INC
LOADING...